Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nissha Printing Co., Ltd. Partners with TactoTek to Deliver Injection Molded Structural Electronics Solutions for Automotive and Home Appliances

Leading In-Mold Decoration (IMD) Supplier Replaces Traditional Electronics with IMSE SolutionKYOTO, JAPAN/OULU, FINLAND – Nissha Printing Co., Ltd.(TYO 7915), a leading manufacturer of In-Mold Decoration (IMD) parts for automotive and home appliance OEMs, today announced that they are partnering with TactoTek, a leading producer of 3D Injection Molded Structural Electronics (IMSE), to collaboratively design and mass produce automotive and home appliance control panels. The first control panel includes a number of electronic functions including printed circuitry, high performance capacitive

Nel ASA: Awarded contract for electrolyser plant in Mexico and celebrates delivery to country number 60

(Oslo, December 13th, 2016) Nel Hydrogen Electrolyser, a division of Nel ASA, has entered into an agreement with Instituto Mexicano del Petróleo (IMP), a research institute, for the delivery of a Nel A-150 electrolyser plant. With this agreement, Nel Hydrogen Electrolyser celebrates delivery as many as 60 different countries worldwide. From Ecuador in the west to Japan in the east, from South Africa in the south to Finland in the north, electrolysers from Nel Hydrogen have been installed and recognised for their reliability amongst global, regional and national companies in a wide span

Exercise of PowerCell's incentive program

Through the exercise of warrants, the fuel cell company PowerCell Sweden AB (publ)  gets a capital injection up to SEK 23.9 million.In order to facilitate the subscription in conjunction with the exercise of PowerCell's incentive program (TO2) for senior executives and key employees, Pareto Securities AB has placed 1,504,554 shares. The incentive program comprises 1,950,520 warrants, corresponding to an equal number of shares. At maximum subscription, PowerCell gets a capital injection of SEK 23.9 million. Gothenburg, Sweden, December 13, 2016 For further

Leasing rate at Iso Omena reaches 95% – entertainment offering increases with opening of activity park and new cinema

CITYCON OYJ    Press release   13. December 2016 at 9.00 hoursIso Omena is becoming a top leisure and entertainment centre in the Helsinki metropolitan area, reflecting Citycon's strategic focus to combine everyday services and entertainment activities. Citycon’s extension and (re)development project at the Iso Omena shopping centre in Espoo in the Helsinki area will be complete in April 2017, when the second phase is set to open. With the signing of several major new tenants, 95% of the shopping centre has already been leased. Iso Omena will soon be the leading leisure and

Ulf Lundahl proposed as new chairman of Attendo

The Nominating Committee of Attendo AB has decided to propose Ulf Lundahl as the new chairman of the board at the annual general meeting 2017.  Ulf Lundahl is currently a board member of Attendo and chairman of the company’s audit committee. Ulf was elected to Attendo’s board in 2014. He is also chairman of Ramirent and Fidelio and a board member of Nordstjernan Kredit, Eltel (acting chairman), Holmen and SHB Regionbank Stockholm. The other proposals of the nominating committee will be presented in the notice of the annual general meeting, to be issued in good time before the meeting,

Bond loan repaid

Bactiguard outstanding bond loan was repaid in full on 12 December. The refinancing solution consists of loans totaling SEK 150 million.The bond loan Bactiguard issued in December 2011, with an initial nominal value of SEK 450 million, an annual interest rate of 11% and a duration of 5 years, matured on 12 December. The outstanding nominal value of SEK 138 million and accrued interest have now been paid in full. The refinancing solution consists, as previously communicated, of two loan commitments which now have been utilized in the form of a bank loan of SEK 100 million maturing 31

SAS YEAR-END REPORT, NOVEMBER 2015–OCTOBER 2016

EARNINGS IN LINE WITH FORECAST - FURTHER ACTIONS INITIATEDAUGUST 2016–OCTOBER 2016 · Income before tax: MSEK 577 (867) · Income before tax and nonrecurring items: MSEK 941 (1,338) · Revenue: MSEK 11,135 (10,903) · Unit revenue (PASK) declined 7.7%[1] · Unit cost (CASK) decreased 8.3%[2] · Net income for the period: MSEK 591 (517) · Earnings per common share: SEK 1.53 (1.31) · The outlook for the full year 2016/2017 is presented on page 8. NOVEMBER 2015–OCTOBER 2016 · Income before tax: MSEK 1,431 (1,417) · Income before tax and nonrecurring items: MSEK

Precise Biometrics to acquire the business of NexID Biometrics - adding liveness detection to its industry leading fingerprint software solutions

Precise Biometrics, a leader in fingerprint software, has entered into an agreement to acquire the assets of NexID Biometrics, a specialist in spoof mitigation and liveness detection solutions for the biometric authentication industry, for 32 million SEK in cash. The acquisition will enable Precise Biometrics to rapidly expand its offering of fingerprint recognition software with liveness detection, significantly increasing security and addressing customer demand for fraud mitigation. The acquisition will create further conditions for growth in the fast developing market for fingerprint

NRC GROUP ASA - APPOINTED TO A CONTRACT IN SWEDEN - SEK 55 MILLION

The Swedish Transport Administration has appointed Svensk Järnvägsteknik AB, a company wholly owned by NRC Group ASA, to a contract for the partial rebuilding of Herrljunga driftsplats. The contract is valued at approximately SEK 55 million,  and will involve rail services such as groundwork, track, electro, signal and telecom. The work will commence in December 2016, and the project is scheduled for completion in November 2017. Closing date for submission of complaints is 10 days from Monday 12 December, and formal contractual signing can take place after this period at the

Herantis Pharma Oyj - Manager's Transactions

Herantis Pharma's Manager's Transactions Herantis Pharma PlcCompany release 13 Dec 2016 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Simula, Pekka Position: Chief Executive Officer Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20161212222423_3 ____________________________________________ Transaction date: 2016-12-12 Venue: FIRST NORTH FINLAND (FNFI)

Vestas - Transactions in connection with share buy-back programme during the period 6-12 December 2016

On 18 August 2016, Vestas initiated a share buy-back programme, ref. Company announcement No. 26/2016 . The programme is implemented in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (the "Safe Harbour” rules). The purpose of the programme is to adjust Vestas’ capital structure and to meet the obligations arising from share based incentive programmes to employees of Vestas. Under the programme Vestas will buy back shares for an amount up to

Nuuka selects Augment Partners as advisor for planned listing on Nasdaq First North Stockholm during 2017

As announced previously Nuuka Solutions Oy (”Nuuka”), of which Cleantech Invest holds the largest share, 35,2%, has been investigating a listing on Nasdaq Stockholm First North. Augment Partners AB (“Augment Partners”) has now been selected as an advisor for the First North Stockholm IPO process. The timing of the listing is estimated to be during 2017. During 2016 Nuuka has grown remarkably by adding several hundred buildings to its customer base and now has more than 800 buildings using Nuuka for more efficient and smarter building management in the Nordic countries and the Netherlands.

THE REQUEST TO AMEND THE TERMS AND CONDITIONS OF THE 2016 SENIOR NOTES HAS BEEN APPROVED

On 18 November 2016 Com Hem Holding AB (publ) announced that its subsidiary NorCell Sweden Holding 3 AB (publ) (the “Issuer”) had initiated a written procedure under its SEK 1,750 million senior unsecured notes due 2021 (ISIN: SE0007730353) (“2016 Senior Notes”) in order to amend the terms and conditions of the 2016 Senior Notes. The written procedure was closed on 12 December 2016. A sufficient majority of noteholders approved the request by the Issuer and the amended terms and conditions (as attached to the notice of written procedure) will become effective immediately. The amended

Targovax to present at DNB healthcare conference

Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target, primarily, treatment-resistant solid tumors, announces that members of its senior management will present a corporate overview at the following conference: DNB Nordic Healthcare conferenceDate: 15 December 2016Participants: Øystein Soug (CEO) and Magnus Jäderberg (CMO)Presentation time: 09:30 CETVenue: DNB, Oslo The presentation will be available to download at www.targovax.com following this event. For further information, please

Study demonstrates the feasibility of targeting human kallikrein-related peptidase 2 (hK2) for detection and monitoring of prostate cancer

A new publication in Science Translational Medicine demonstrates that in vivo targeting of the enzyme human kallikrein-related peptidase 2 (hK2) is a powerful tool that can be used for detection of prostate cancer and monitoring treatment by quantifying the activity of the androgen receptor pathway.The authors of the article “Internalization of secreted antigen–targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis” (Thorek et al., Sci Transl Med . 2016 Nov 30;8(367))” hK2 in mouse

Handelsbanken refutes erroneous information in Dagens Industri

The Dagens Industri newspaper (DI) has published on 12 December 2016 on its website and on 13 December in its paper edition, erroneous information regarding the Chairman of the Handelsbanken Board, Pär Boman, and his pension terms. Dagens Industri erroneously writes that Pär Boman, after stepping down as Group Chief Executive in March 2015, “was compensated for his loss of salary through a change in his pension – something that increased costs to shareholders by SEK 54 million.” DI’s information, statements and conclusions are groundless and completely erroneous. The facts are as

Etrion Completes Phase One of Sale of Italian Solar Portfolio to EF Solare Italia

December 12, 2016, Miami, Florida, United States – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, today announced that it has completed phase one of the previously disclosed sale of its Italian solar portfolio to EF Solare Italia, a joint venture owned equally by Enel Green Power S.p.A. and Fondo Italiano per le Infrastrutture “F2i”. EF Solare Italia has purchased Etrion S.p.A., which owns 53.4 MW of Etrion’s total portfolio in Italy, for cash consideration of Euro 73.1 million and the assumption of related project-level debt of

NEXT Launches Fee-Based Platform Powered by BNY Mellon’s Pershing

Independent broker-dealer NEXT Financial Group, Inc. (NEXT), today launched their new, low-cost fee-based platform, NEXT Select, made available through Pershing’s NetX360® technology for all NEXT Representatives. NEXT Select was developed over the last year by key members of the broker-dealer’s executive team in conjunction with BNY Mellon’s Pershing. The multi-manager platform is designed to help advisors offer a wide range of flexible and competitive investment options for clients. “The NEXT Select Platform is an incredible initiative. All of us at NEXT have put an enormous amount

Candlewick Press Acquires New YA Novel From National Book Award-Winning Author M. T. Anderson

Scheduled for publication in fall 2017, Landscape with Invisible Hand weaves themes of truth, art, romance, commerce, and capitalism Somerville, MA, November 18, 2017 — Candlewick Press announced today that it will publish a sharply wrought new satiric novel by M. T. Anderson, the gifted National Book Award–winning author of a wide range of titles in a variety of genres. Landscape with Invisible Hand, an exploration of art and truth that marks Anderson’s first return to a future-Earth setting since the now-classic Feed, is scheduled for release on September 12, 2017. Candlewick Press

Library CEO receives CMS game ball

The Library received a "game ball" from Charlotte-Mecklenburg Schools Dec. 7 during its annual “State of Our Schools” event.  Superintendent Ann Clark thanked the Library for being part of an incredible collaboration. Said Clark, "We are so fortunate to have the Charlotte Mecklenburg Library as our partner. Our ONE Access (TM) program allows CMS students to use their student IDs for full access to the library's amazing range of resources - the books, the e-books, movies, technology and more. Our partnership with the library means every student has access - and I want to recognize Lee

ExpreS2ion and ABIVAX announce development collaboration on the Ebola prophylaxis and treatment program, ABX544

Horsholm, Denmark and Paris, France, December 12, 2016 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, and ABIVAX S.A., (Euronext Paris: FR0012333284 – ABVX), an innovative biotechnology company targeting the immune system to eliminate viral disease, have entered into a service agreement and a term sheet for a commercial license agreement under which ExpreS2ion and ABIVAX collaborate in the development of their proprietary prophylactic and treatment for Ebola virus infection, ABX544. The financial terms of the agreement were

SIGNING OF TERM SHEET IN RELATION TO THE REFINANCING OF FINANCIAL OBLIGATIONS

The Board of Directors (the "Board") of Emas Offshore Limited (the "Company", together with its subsidiaries, the "Group") refers to the announcement released by the Company dated 30 October 2016 where the Company announced that the Group has reached in-principle agreements with the substantial majority of its principal bankers on the refinancing of its financial obligations and the provision of additional working capital facilities (the "Ongoing Initiatives"). The Company is pleased to announce that the Group has reached agreement with all its financial lenders to refinance its

Nordic Trustee & Agency AB (publ): Request for consent - Bergteamet AB (publ) SEK 200,000,000 Senior Secured Callable Zero Interest Bonds 2015/2020

Nordic Trustee & Agency AB (publ) acts as agent (the "Agent") for the holders of the bonds (the "Holders") in the above mentioned bond issue ISIN SE0006886883 (with an aggregated outstanding amount of SEK 200,000,000) (the "Bonds") issued by Bergteamet AB (publ) (the "Issuer"). The Issuer initiated a written procedure on 16 November 2016. On the expiry of the stipulated timeperiod for Holders to reply to the request, Holders representing at least 20% of the adjusted nominal amount had not replied to the request and therefore a quorum for the written procedure did not exist. The Issuer

AKTIA BANK PLC: SHARE REPURCHASE 12.12.2016

AKTIA BANK PLC: SHARE REPURCHASE 12.12.2016                                                            Helsinki Stock Exchange                                                      Trade date                                       12.12.2016                        Bourse trade                                    PURCHASEAmount                                            7000 shares Total cost                                         69 088,00 EUR           Average price / share                       9,869714 EUR           Highest price / share                        9,90 EUR

There are no items matching the current filter
There are no more items matching the current filter
Back to top